Ignite Creation Date:
2024-05-05 @ 11:34 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00085787
Status:
COMPLETED
Last Update Posted:
2020-10-14
First Post:
2004-06-14
Brief Title:
A Study of ARRY-142886 in Patients With Advanced Cancer
Sponsor:
Array Biopharma now a wholly owned subsidiary of Pfizer
Organization:
Array BioPharma
Study Overview
Official Title:
None
Status:
COMPLETED
Status Verified Date:
2020-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a Phase 1 study during which patients with advanced solid tumors will receive investigational study drug ARRY-142886
This study has 2 parts In the first part patients will receive increasing doses of study drug in order to achieve the highest dose of study drug possible that will not cause unacceptable side effects Approximately 25 patients from the US will be enrolled in Part 1 Completed
In the second part of the study patients will receive the best dose of study drug determined from the first part of the study and will be followed to see what side effects the study drug causes and what effectiveness the study drug has if any in treating the cancer Approximately 35 patients from the US will be enrolled in Part 2 Completed
This study has 2 parts In the first part patients will receive increasing doses of study drug in order to achieve the highest dose of study drug possible that will not cause unacceptable side effects Approximately 25 patients from the US will be enrolled in Part 1 Completed
In the second part of the study patients will receive the best dose of study drug determined from the first part of the study and will be followed to see what side effects the study drug causes and what effectiveness the study drug has if any in treating the cancer Approximately 35 patients from the US will be enrolled in Part 2 Completed
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None